<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | James Harris | Activity</title>
	<link>http://toxicdolls.com/members/rabbidead92/activity/</link>
	<atom:link href="http://toxicdolls.com/members/rabbidead92/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for James Harris.</description>
	<lastBuildDate>Fri, 06 Nov 2026 18:09:15 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">47c0de797c5df15cb2bb5ee6e11a8037</guid>
				<title>James Harris posted an update: roteins and thus single transporter expression systems might [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/41213/</link>
				<pubDate>Thu, 10 Jul 2025 15:02:37 +0000</pubDate>

									<content:encoded><![CDATA[<p>roteins and thus single transporter expression systems might lead to over- or underestimation of drug-drug interactions.The introduction of anti-CD20 monoclonal antibodies such as rituximab, ofatumumab, or obinutuzumab improved the therapy of B-cell malignancies even though the precise physiological role and regulation of CD20 remains unclear.&hellip;<span class="activity-read-more" id="activity-read-more-41213"><a href="http://toxicdolls.com/activity-2/p/41213/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9c7071c205ad32f7f5b61a536da050ee</guid>
				<title>James Harris became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/41124/</link>
				<pubDate>Thu, 10 Jul 2025 14:13:49 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>